SCHEMBL25523280

SCHEMBL25523280

COC(=O)c1ccccc1-c1cccc2c(Br)cccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.56
SLC6A4 P31645 3/20 0.50
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
AHR P35869 1/20 0.49
SLC6A2 P23975 1/20 0.48
PRNP P04156 1/20 0.47
TSHR P16473 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 2/20 0.47
MAPT P10636 1/20 0.47
MAPK10 P53779 1/20 0.47
PTK2B Q14289 1/20 0.47
NCOA1 Q15788 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
ALDH1A1 P00352 3/20 0.46
CFTR P13569 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18302011 0.94 SLC6A3 (0.56) SLC6A3SLC6A4KMT2AMEN1SLC6A2
SCHEMBL18539206 0.90 SLC6A3 (0.59) SLC6A3SLC6A4KMT2AMEN1SLC6A2
SCHEMBL15525214 0.86 SLC6A3 (0.63) SLC6A3SLC6A4KMT2AMEN1SLC6A2
SCHEMBL2646933 0.86 KMT2A (0.57) SLC6A3KMT2AMEN1AHRPRNP
SCHEMBL29583255 0.86 KMT2A (0.57) SLC6A3KMT2AMEN1AHRPRNP
SCHEMBL5072166 0.86 SLC6A3 (0.59) SLC6A3SLC6A4KMT2AMEN1SLC6A2
SCHEMBL20565635 0.83 SLC6A3 (0.47) SLC6A3SLC6A4KMT2AMEN1AHR
SCHEMBL10010690 0.83 SLC6A3 (0.58) SLC6A3SLC6A4KMT2AMEN1SLC6A2
SCHEMBL69464 0.82 SLC6A3 (0.67) SLC6A3SLC6A4KMT2AMEN1SLC6A2
SCHEMBL13324417 0.81 SLC6A3 (0.50) SLC6A3SLC6A4KMT2AMEN1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247898-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2023-08-03 US disclosed
US-20230247898-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2023-08-03 US disclosed
US-11653562-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-05-16 US disclosed
US-11653562-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11653562-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same OPA1, ODC1, TMEM109 SLC6A3 4154/4885SLC6A4 3616/4885KMT2A 2798/4885
US-20230247898-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OPA1, ODC1, TMEM109 SLC6A3 4154/4885SLC6A4 3616/4885KMT2A 2798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.